Deutsche Bank AG Buys 20,504 Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE)
Deutsche Bank AG boosted its stake in shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) by 67.6% in the fourth quarter, Holdings Channel reports. The institutional investor owned 50,818 shares of the biopharmaceutical company’s stock after purchasing an additional 20,504 shares during the period. Deutsche Bank AG’s holdings in Sage Therapeutics were worth $276,000 […]
